With our nanotechnology PuranoTec® we focus on developing nanodrugs for unmet medical needs such as Borderline Personality Disorder and Fibromyalgia Syndrome.

We are currently redesigning our website to keep you informed about our latest clinical developments  and achievements. 

We look forward to welcoming you to our new website in mid-October 2026

Contact

 

Apurano Pharmaceuticals GmbH

Birkerfeld 12
83627 Warngau, Germany
Telefon: +49 8024 46869 70
E-Mail: info@apurano.de

Handelsregister beim Amtsgericht München, HRB 213986
Umsatzsteueridentifikationsnummer: DE 296539720

Zuständige Aufsichtsbehörde: Regierung von Oberbayern

© 2026 | Apurano Pharmaceuticals GmbH | Birkerfeld 12 | 83627 Warngau Deutschland